115 related articles for article (PubMed ID: 35643579)
21. Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model.
Kutikov A; Egleston BL; Canter D; Smaldone MC; Wong YN; Uzzo RG
J Urol; 2012 Dec; 188(6):2077-83. PubMed ID: 23083850
[TBL] [Abstract][Full Text] [Related]
22. Predictive Capacity of 3 Comorbidity Indices in Estimating Survival Endpoints in Women With Early-Stage Endometrial Carcinoma.
Al Feghali KA; Robbins JR; Mahan M; Burmeister C; Khan NT; Rasool N; Munkarah A; Elshaikh MA
Int J Gynecol Cancer; 2016 Oct; 26(8):1455-60. PubMed ID: 27488218
[TBL] [Abstract][Full Text] [Related]
23. Competing Risks for Mortality in Patients With Asymptomatic Pancreatic Cystic Neoplasms: Implications for Clinical Management.
Kwok K; Chang J; Duan L; Huang BZ; Wu BU
Am J Gastroenterol; 2017 Aug; 112(8):1330-1336. PubMed ID: 28534524
[TBL] [Abstract][Full Text] [Related]
24. Effect of age as a continuous variable in early-stage endometrial carcinoma: a multi-institutional analysis in China.
Sun S; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Wang W; Jin M; Zhang F; Hou X; Wei L; Hu K
Aging (Albany NY); 2021 Aug; 13(15):19561-19574. PubMed ID: 34371481
[TBL] [Abstract][Full Text] [Related]
25. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
26. The impact of geriatric characteristics and comorbidities on distant metastases and other cause mortality in older women with non-metastatic breast cancer treated with primary endocrine therapy.
Waaijer MEC; Lemij AA; de Boer AZ; Bastiaannet E; van den Bos F; Derks MGM; Kroep JR; Liefers GJ; Portielje JEA; de Glas NA
Breast Cancer Res Treat; 2023 Oct; 201(3):471-478. PubMed ID: 37479944
[TBL] [Abstract][Full Text] [Related]
27. Importance of Considering Competing Risks in Time-to-Event Analyses: Application to Stroke Risk in a Retrospective Cohort Study of Elderly Patients With Atrial Fibrillation.
Abdel-Qadir H; Fang J; Lee DS; Tu JV; Amir E; Austin PC; Anderson GM
Circ Cardiovasc Qual Outcomes; 2018 Jul; 11(7):e004580. PubMed ID: 29997149
[TBL] [Abstract][Full Text] [Related]
28. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
[TBL] [Abstract][Full Text] [Related]
29. Age-adjusted Charlson comorbidity index is a significant prognostic factor for long-term survival of patients with high-risk prostate cancer after radical prostatectomy: a Bayesian model averaging approach.
Lee JY; Kang HW; Rha KH; Cho NH; Choi YD; Hong SJ; Cho KS
J Cancer Res Clin Oncol; 2016 Apr; 142(4):849-58. PubMed ID: 26660495
[TBL] [Abstract][Full Text] [Related]
30. Comparison of different comorbidity measures for oral cancer patients with surgical intervention: A longitudinal study from a single cancer center.
Lee CC; Ho HC; Su YC; Chen PC; Yu CH; Yang CC
Auris Nasus Larynx; 2016 Jun; 43(3):322-9. PubMed ID: 26642942
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania.
Furau A; Tit DM; Furau C; Bungau S; Furau G; Toma MM; Cirstoveanu CG; Petre I; Todor DS; Romosan RS; Craina M
Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577868
[No Abstract] [Full Text] [Related]
32. Socioeconomic Status-Related Parameters as Predictors of Competing (Non-Bladder Cancer) Mortality after Radical Cystectomy.
Froehner M; Muallah D; Koch R; Hübler M; Borkowetz A; Heberling U; Huber J; Wirth MP; Thomas C
Urol Int; 2020; 104(1-2):62-69. PubMed ID: 31639810
[TBL] [Abstract][Full Text] [Related]
33. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
[TBL] [Abstract][Full Text] [Related]
34. [Impact of the COVID-19 epidemic in Friuli Venezia Giulia Region (Northern Italy): assessment of factors associated with the risk of death by competing risks analysis].
Castriotta L; Rosolen V; Barbiero F; Tomietto M; de Dottori M; Barbone F; Zamaro G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):128-135. PubMed ID: 33412803
[TBL] [Abstract][Full Text] [Related]
35. Noncancer health events as a leading cause of competing mortality in advanced head and neck cancer.
Kwon M; Roh JL; Song J; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Ann Oncol; 2014 Jun; 25(6):1208-14. PubMed ID: 24669018
[TBL] [Abstract][Full Text] [Related]
36. Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions.
Rees MJ; Liao H; Spillane J; Speakman D; McCormack C; Donahoe S; Pohl M; Webb A; Gyorki D; Henderson MA
Eur J Surg Oncol; 2016 Sep; 42(9):1359-66. PubMed ID: 26899940
[TBL] [Abstract][Full Text] [Related]
37. Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer.
Tobias CJ; Chen L; Melamed A; St Clair C; Khoury-Collado F; Tergas AI; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
JAMA Netw Open; 2020 Dec; 3(12):e2028612. PubMed ID: 33295973
[TBL] [Abstract][Full Text] [Related]
38. Predictors of competing mortality in advanced head and neck cancer.
Mell LK; Dignam JJ; Salama JK; Cohen EE; Polite BN; Dandekar V; Bhate AD; Witt ME; Haraf DJ; Mittal BB; Vokes EE; Weichselbaum RR
J Clin Oncol; 2010 Jan; 28(1):15-20. PubMed ID: 19933920
[TBL] [Abstract][Full Text] [Related]
39. Causes of mortality after dose-escalated radiation therapy and androgen deprivation for high-risk prostate cancer.
Tendulkar RD; Hunter GK; Reddy CA; Stephans KL; Ciezki JP; Abdel-Wahab M; Stephenson AJ; Klein EA; Mahadevan A; Kupelian PA
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):94-9. PubMed ID: 23920389
[TBL] [Abstract][Full Text] [Related]
40. The effect of adenomyosis on endometrial cancer: a university hospital-based cohort study.
Celik E; Goksever Celik H; Sozen H; Onder S; Tosun OA; Topuz S; Salihoglu MY
J Obstet Gynaecol; 2022 Jan; 42(1):158-165. PubMed ID: 34895006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
